Based on the prescribing information for the coronavirus vaccine, the side effects are mild to moderate and generally resolve within three days.

Coronavirus – the second year

More than a year has passed since the Chinese authorities informed the WHO of the emergence of a new, rapidly spreading virus. Since then, there has hardly been a person in the world who has not heard the term Covid-19, and more and more people are mourning a family member or friend with whom the new disease has ended while stocks have run out. collapsed in weeks and our entire lives have been rewritten by the epidemic. By now, the vaccines have been completed, which in turn raises not only hope, but again many questions, while not only stopping the virus, but also threatening another mutation. You can find the details of this fight in our article series.

The SPC for the use of the Russian Sputnik V vaccine has been published on the website of the National Institute of Pharmacy and Food and Health (OGYÉI).

The national medical director, Cecília Müller, had already said in a press conference in the operational staff on Tuesday that the drug would not be used to vaccinate people with chronic diseases. This is also supported by the information published on the OGYÉI website, according to which it is not recommended to administer the vaccine between other people.

  • chronic kidney disease or liver disease, endocrine diseases
  • major thyroid problems, poorly treated diabetes,
  • severe hematopoietic diseases, epilepsy and other diseases of the central nervous system,
  • acute coronary syndrome and acute stroke, myocarditis, pericarditis, pericarditis,
  • for people with autoimmune diseases,
  • in case of malignancy.

The package leaflet indicates that the second dose of the vaccine is contraindicated if serious complications (anaphylactic shock, severe allergic reaction throughout the body, seizures, fever over 40 ° C, etc.) occur after the first dose. They are also warned not to give the vaccine if someone has a body temperature over 37 ° C, this will be controlled on the spot.

The vaccine has not yet been given to pregnant or lactating mothers or people under the age of 18 because, as with other licensed vaccines, there is not enough information about how the vaccine affects them.

According to the document, the side effects of Sputnik V are the same as with other coronavirus vaccines: short-term flu-like symptoms such as chills, fever, joint pain, muscle pain, weakness and swelling may appear. at the injection site.

[A magyaroknak is érdemes lesz megfogadniuk a szabályt, amelyre az első beoltottakat figyelmeztetik]

OGYÉI has also published another brochure, specifically for vaccinated people.

Cecília Müller told an operative court briefing on Tuesday that general practitioners in Budapest were asked to search for people to be vaccinated with Russian Sputnik V at vaccination points. Five to five people are expected to be nominated. It says there are currently 20,000 Sputnik V vaccines in the country, but they are still being tested.

Experts from the National Institute of Pharmacy and Food and Health (OGYÉI) issued a provisional authorization for the Russian vaccine on January 20, when they said that the NNK had not yet tested the drug and would have the last word they wanted. be used in Hungary. After OGYÉI granted temporary permission for the vaccine, Foreign Minister Péter Szijjártó announced that the Hungarian government would buy 2 million doses of it in three installments.

There have been several concerns about the Russian vaccine in the past, one of which was that staff at the National Institute of Pharmacy and Food Health received a different clinical trial than the one that will eventually hit the market. However, the Director General of OGYÉI stated that they had received answers to all their questions during the vaccine authorization process.

In one of the best known medical journals in the world, The lancetThey also dealt with Sputnik V. The vaccine, based on an evaluation of the results of 20,000 participants from the third phase of the vaccine clinical trial, was written to find the vaccine to be 91.6 percent effective.

Even after the article in the magazine, the Hungarian Medical Chamber stated that there were no documents related to the use of vaccines on the National Pharmaceutical and Food Health website. In the absence of these, they would not be able to recommend the product to their colleagues. OGYÉI promised that the Russian vaccine documents would be made public before the mass vaccination.

Minister Miklós Kásler announced last Sunday that the National Center for Public Health had authorized the Sputnik Law.

If you ever want to know about similar things, check out the HVG Tech Facebook page for scientific news.



The number of independent publishing offices of power is steadily declining, and those that still exist are trying to stay afloat with a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it.

And we promise to keep doing our best for you in all circumstances!

They requested the authorization of Sputnik V from the European Medicines Agency



MTI
Technology

They can already be vaccinated in Hungary, and the Russian vaccine will soon arrive in the European Union.

The Sputnik V figures, according to the German health minister, are encouraging



MTI
World

Preparation for the production of the Russian vaccine would take four to five months in Germany.